This condition is not a work of fiction. It is a terrifying reality known as an inherited form of frontotemporal dementia, or FTD.
Bestselling author Robert Kolker, widely acclaimed for his previous deep dive into complex family crises in Hidden Valley Road, turns his investigative lens toward this devastating condition in his new book, The Vanishing Family: Love, Fate, and the Quest to End Dementia. The work offers a heartbreaking journey into a poorly understood medical phenomenon that slowly chips away at the core of human identity. Recently, Kolker sat down to discuss how he crossed paths with the family featured in his book, the complex emotional landscape surrounding genetic testing, and what FTD ultimately reveals about the fragile nature of the self.
Encountering a Family Defined by a Single Gene
Recounting how he came to tell this specific story, Kolker explains that the family actually sought him out. Having read Hidden Valley Road, a member of the family reached out with a striking proposition. "We have a rare disease, and we have nine children in our family," the relative told him.
At the time, Kolker had just finished spending several years researching schizophrenia, a complex condition that, as medical science understands it, has no single known cause, whether genetic or environmental. In stark contrast, this family was dealing with an incurable condition driven by a precise, undeniable culprit: a single mutated gene.
Kolker recalls his initial reaction to the discovery, reflecting on the modern promise of medical science. "And I said, ‘Aren’t we in the era of genetic editing? Couldn’t CRISPR or some other tool wipe out this problem by lunch tomorrow?’ And she said, ‘That’s what we would like to know.’"
Unlike Alzheimer’s disease, which primarily attacks cognition and memory, this specific form of frontotemporal dementia strikes personality first. Family members and loved ones who were once cherished suddenly appear indifferent or detached, a transformation that proves intensely painful for those left behind. Beyond the heartbreak, however, the disease forces a profound philosophical question: if a personality can be fundamentally altered by a single malfunctioning gene, what exactly constitutes a personality in the first place? Why are individuals the specific people they are?
For Kolker, the most relatable and haunting question centers on the elusive nature of identity. While everyone changes naturally over decades—acknowledging, for instance, that an eighty-year-old bears little resemblance to their sixteen-year-old self—the drastic, rapid shift caused by FTD raises deeper inquiries into what makes an individual truly themselves. This profound mystery is what draws many scientific researchers to the field. Experts see FTD as a unique intersection where psychiatry and neurobiology overlap, offering a potential key to understanding the very roots of the human self.
The Heavy Burden of the Unknown: To Test or Not to Test
The psychological weight of genetic inheritance naturally brings up difficult questions surrounding medical ethics and personal choice. For outsiders looking in, the decision-making process can seem baffling. Given a fifty-fifty risk of developing a debilitating condition that leads to total dependency, an outside observer might assume an ethical obligation to seek out testing immediately in order to prepare families and plan for the future. Yet, the reality faced by those living in the shadow of FTD is infinitely more complex.
When Kolker began his research, he shared the assumption that, if placed in the same position, he would want all the facts as quickly as possible. As a reporter, gathering information and confronting reality head-on felt like the only logical path. Over time, however, what initially appeared to be mere psychological rationalization revealed itself to be an authentic, visceral reaction to the terror of living through generational trauma.
Kolker points to the story of one family member who spent her entire childhood watching her mother gradually fade and disappear before her eyes. By the time genetic testing became available for her specific situation, she was already an adult, married with children who were entering their teenage years. For her, the threat manifested as a triple nightmare: the fear that she might carry the gene, the terror that she might have passed it down, and the dread of watching her own children face the same fate. She suffered in silence for a decade, the psychological toll mounting steadily until she was finally emotionally prepared to face the truth.
Another striking case involved a woman who chose to have children despite knowing she tested positive for the genetic mutation. Having attempted selective embryo transfer without success, she ultimately conceived naturally and decided to embrace a radical form of optimism. Confronted with the certainty of her genetic status, she challenged the deterministic view of her future, asking who could truly predict what lies ahead or claim the moral authority to dictate whether her life—or the life of her child—was worth living. While critics might view this stance through the lens of rationalization, Kolker highlights it as an assertion of hope in the face of overwhelming odds, asking why a person should be barred from experiencing parenthood solely because of their genetic code.
Living With the Aftermath: Tragedy for the Caretaker
Mental health conditions often fall into distinct categories: those that cause internal distress to the individual experiencing them, such as clinical depression, and those that may not distress the individual directly but inflict profound pain on those around them, such as certain personality disorders. While FTD is a neurological disease rather than a traditional psychiatric illness, its social footprint heavily mirrors the latter category.
Patients suffering from FTD frequently experience a symptom known as anosognosia, meaning they are largely unaware of their own cognitive and behavioral deficits. They do not typically experience prolonged personal anguish over their condition because, from their own perspective, nothing is wrong. The suffering is instead absorbed entirely by the caretakers, spouses, and children who bear witness to the dismantling of their loved one’s personality.
This dynamic often sparks preemptive dread among family members. Kolker notes that once a definitive diagnosis was established, several members of the family discussed how they might choose to end their lives should they begin to exhibit symptoms of decline. Yet, as the disease progressed individually through various family members, none ultimately chose self-harm. The anticipation of the disease proved to be vastly more terrifying than the reality of living through its initial stages. Instead of despair driving self-destruction, the situation often transforms into a profound endurance of care.
Through decades of shared struggle, families become deeply enmeshed with the altered versions of their relatives. Kolker’s book highlights poignant examples of this enduring bond, such as a woman named Sue who spent thirty years caring for her sister Christy. Despite the profound changes wrought by the illness that rendered Christy a fundamentally different person, the familial love remained steadfast, sustaining daily caregiving over the span of three decades.
Looking Toward Medical Horizons
Like many rare conditions, frontotemporal dementia has historically suffered from a lack of widespread research attention and dedicated funding. However, the scientific landscape is currently experiencing a shift that offers a glimmer of hope for affected families.
Researchers and major pharmaceutical companies are increasingly focusing their attention on the tau protein, a biological marker that plays a critical role in the progression of numerous forms of dementia, including Alzheimer’s disease. Because individuals carrying the genetic mutation for FTD share significant issues related to tau protein accumulation, the massive financial and scientific momentum currently driving Alzheimer’s drug development could yield vital trickle-down benefits for the FTD community. As science moves closer to understanding and targeting these underlying proteins, families living under the shadow of genetic dementia may finally find a path toward effective intervention.
